Oral Presentation

C. Friedrich, V. Hurez, R. Myers, M. Reed, K. Dasika, K. Kudrycki, R. Sheehan, T. Zhang, G. Gauderat, A. Aussy, L. Chadli, F. Chassereau, S. Fouliard, S. Hubert, E. Desvaux, P. Soret, L. Laigle, P. Moingeon

Predicted efficacy of a pan neutralizing anti interferon-alpha (IFN-α) monoclonal antibody in a virtual systemic lupus erythematosus (SLE) patient cohort using a mechanistic SLE PhysioPD QSP model

Presented by Servier and Rosa at the Quantitative Systems Pharmacology Conference 2022 (QSPC2022), April 2022,

Visit Url

Poster

C. Friedrich, V. Hurez, R. Myers, M. Reed, K. Dasika, K. Kudrycki, R. Sheehan, T. Zhang, G. Gauderat, A. Aussy, L. Chadli, F. Chassereau, S. Fouliard, S. Hubert, E. Desvaux, P. Soret, L. Laigle, P. Moingeon

Predicted efficacy of a pan neutralizing anti interferon-alpha (IFN-α) monoclonal antibody in a virtual systemic lupus erythematosus (SLE) patient cohort using a mechanistic SLE PhysioPD QSP model.

Presented by Servier and Rosa at the Quantitative Systems Pharmacology Conference 2022 (QSPC2022), April 2022,

Visit Url

White Paper

William C. Brastow, PhD

Commercializing Life Science Products

Which Product Properties Are Important in Convincing Physicians and Patients to Use My Product? And How to Ask This Question.

Download (pdf)